Suicidal ideation among people with Parkinson's disease and comparison with a control group

Detection of suicidal ideation (SI) is key for trying to prevent suicide. The aim of this study was to analyze the frequency of SI and related factors in Spanish people with Parkinson's Disease (PwPD) and to compare them with a control group.

• Publication year

  2023

• Venue

  International Journal of Geriatric Psychiatry

• Publication date

  2023-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/gps.5919PMID 37147900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trial of Prasinezumab in Early-Stage Parkinson's Disease.

  2022cited by this paper
• High frequency of Depressive Disorders and Suicidal Phenomena in Late-Stage Parkinson´s Disease – A Cross-Sectional Study

  2022cited by this paper
• Frequency of Depressive Disorders in Parkinson’s Disease: A Systematic Review and Meta-Analysis

  2022cited by this paper
• Association between new-onset Parkinson’s disease and suicide risk in South Korea: a nationwide cohort study

  2022cited by this paper
• Suicidal ideation in early-onset Parkinson’s disease

  2021cited by this paper
• Predictors of clinically significant quality of life impairment in Parkinson’s disease

  2021cited by this paper
• Mood in Parkinson's disease: From early‐ to late‐stage disease

  2020cited by this paper
• Risk of Suicide Among Patients With Parkinson Disease.

  2020cited by this paper
• Parkinson's Disease-Related Risk of Suicide and Effect of Deep Brain Stimulation: Meta-Analysis

  2020cited by this paper
• Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort.

  2019cited by this paper
• COPPADIS‐2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

  2019cited by this paper
• The clinical correlates of suicidal ideation in Parkinson's disease.

  2019influential reference
• Suicide in Parkinson’s disease

  2019cited by this paper
• Suicidal risk and demoralization in Parkinson disease

  2019cited by this paper
• Suicide in Parkinson's disease: A systematic review.

  2019influential reference
• Suicide in Parkinson's Disease

  2018cited by this paper
• A Comprehensive Model of Predictors of Suicide Attempt in Depressed Individuals and Effect of Treatment-Seeking Behavior: Results From a National 3-Year Prospective Study.

  2018influential reference
• Clinical epidemiology of long-term suicide risk in a nationwide population-based cohort study in South Korea.

  2018cited by this paper
• Suicidal ideation, perceived disability, hopelessness and affective temperaments in patients affected by Parkinson's disease

  2018cited by this paper
• Dysregulation of Striatal Dopamine Receptor Binding in Suicide

  2017cited by this paper
• The Association Between Physical Illness/Medical Conditions and Suicide Risk

  2016cited by this paper
• COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression

  2016cited by this paper
• The International Handbook of Suicide Prevention

  2016cited by this paper
• Suicidal ideation in Parkinson's disease

  2016cited by this paper
• Neuropsychiatric co-morbidities in non-demented Parkinson's disease

  2015cited by this paper
• Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease

  2015cited by this paper
• Toward a biosignature for suicide.

  2014cited by this paper
• Suicide Prevention

  2014cited by this paper
• Suicidal behavior among Turkish patients with Parkinson’s disease

  2014cited by this paper
• The neurobiology of suicide.

  2014cited by this paper
• Suicide without depression after withdrawal of a dopamine agonist in a patient with Parkinson's disease.

  2011cited by this paper
• Suicide and suicidal ideation in Parkinson's disease.

  2010cited by this paper
• Anxiety disorders in Parkinson's disease: Prevalence and risk factors

  2010cited by this paper
• Dopamine agonist withdrawal syndrome in Parkinson disease.

  2010cited by this paper
• Suicidal Ideation in Parkinson's Disease

  2009cited by this paper
• A systematic review of prevalence studies of depression in Parkinson's disease

  2008cited by this paper
• Suicidal and death ideation in Parkinson's disease

  2008cited by this paper
• Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease

  2006cited by this paper
• Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease.

  2001cited by this paper
• Are Patients with Parkinson's Disease Suicidal?

  2001cited by this paper
• Are patients with Parkinson's disease more likely to have periventricular hyperintensities develop?

  1996cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 4th ed

  1995cited by this paper
• Subsyndromal symptomatic depression: a new mood disorder?

  1994cited by this paper
• Depression and Parkinson's disease: a review.

  1992cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper

• Anxiety is associated with increased risk of suicidality in Parkinson's disease.

  2026cites this paper
• Reliability and validity of the short quality of life scale among bank employees in Guangxi, China

  2025cites this paper
• Suicide attempt in a dopamine agonist withdrawal syndrome in Parkinson's disease.

  2024cites this paper
• Risk of Suicidal Ideation and Behavior in Individuals With Parkinson Disease: A Systematic Review and Meta-Analysis.

  2023cites this paper